Endocannabinoids and the Neurochemistry of GluttonyKIRKHAM, Tim.Journal of neuroendocrinology. 2008, Vol 20, Num 9, pp 1099-1100, issn 0953-8194, 2 p.Article

Atypical cannabinoid stimulates endothelial cell migration via a G_i/G_o-coupled receptor distinct from CB₁, CB₂ or EDG-1FONG MING MO; OFFERTALER, Laszlo; KUNOS, George et al.European journal of pharmacology. 2004, Vol 489, Num 1-2, pp 21-27, issn 0014-2999, 7 p.Article

Récepteurs cannabinoïdes: Fonctions cellulaires = Cannabinoid receptors : cellular functionsBOUABOULA, M; CASELLAS, P.Douleur et analgésie. 2001, Vol 14, Num 4, pp 207-211, issn 1011-288XArticle

Cannabis, cannabinoids and reproductionPARK, Boram; MCPARTLAND, John M; GLASS, Michelle et al.Prostaglandins, leukotrienes and essential fatty acids. 2004, Vol 70, Num 2, pp 189-197, issn 0952-3278, 9 p.Article

ENDOCANNABINOID SYSTEM AND FEAR CONDITIONINGRESSTEL, Leonardo B. M; MOREIRA, Fabrício A; GUIMARAES, Francisco S et al.Vitamins and hormones. 2009, Vol 81, pp 421-440, issn 0083-6729, 20 p.Article

CB₁ and CB₂ receptor-mediated signalling: a focus on endocannabinoidsMCALLISTER, Sean D; GLASS, Michelle.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 161-171, issn 0952-3278Article

Constitutive activity of cannabinoid-2 (CB₂) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242MANCINI, I; BRUSA, R; QUADRATO, G et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 382-391, issn 0007-1188, 10 p.Article

CB₂ receptor-mediated migration of immune cells : it can go either wayMILLER, A. M; STELLA, N.British journal of pharmacology. 2008, Vol 153, Num 2, pp 299-308, issn 0007-1188, 10 p.Article

Toxicité générale du cannabis = Systemic toxicity of cannabisNAHAS, G; RITS, R; LATOUR, C et al.La Presse médicale (1983). 1992, Vol 21, Num 42, pp 2030-2033, issn 0755-4982Article

Exploiting modern cannabinoid pharmacology for therapeutic gain?RITTER, James M.British journal of clinical pharmacology. 2012, Vol 73, Num 5, pp 671-673, issn 0306-5251, 3 p.Article

Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasksHARLOE, John P; THORPE, Andrew J; LICHTMAN, Aron H et al.Learning & memory (Cold Spring Harbor, N.Y.). 2008, Vol 15, Num 7-12, pp 806-809, issn 1072-0502, 4 p.Article

Endocannabinoids and the control of energy balanceMATIAS, Isabel; DI MARZO, Vincenzo.Trends in endocrinology and metabolism. 2007, Vol 18, Num 1, pp 27-37, issn 1043-2760, 11 p.Article

Determination of ¹⁴C-THC and ¹⁴C-11-OH-THC from in vitro metabolism studies by mass spectrometry (GC-MS) or on-line radiometric detection (HPLC-R)CONGOST, M; DE LA TORRE, R; SEGURA, J et al.Journal of pharmaceutical and biomedical analysis. 1990, Vol 8, Num 8-12, pp 1095-1099, issn 0731-7085, 5 p.Conference Paper

Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agentODAN, Masahide; ISHIZUKA, Natsuki; YASUI, Kiyoshi et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2898-2901, issn 0960-894X, 4 p.Article

Therapeutic potential of cannabinoid receptor ligands : Current statusSINGH, J; BUDHIRAJA, S.Methods and findings in experimental and clinical pharmacology. 2006, Vol 28, Num 3, pp 177-183, issn 0379-0355, 7 p.Article

Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory painGUINDON, Josée; DE LEAN, André; BEAULIEU, Pierre et al.Pain (Amsterdam). 2006, Vol 121, Num 1-2, pp 85-93, issn 0304-3959, 9 p.Article

The role of the CB₁ receptor in the regulation of sleepMURILLO-RODRIGUEZ, Eric.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 6, pp 1420-1427, issn 0278-5846, 8 p.Article

Cannabinoid Type 1 Receptor : Another Arrow in the Adipocytes' BowBELLOCCHIO, L; CERVINO, C; VICENNATI, V et al.Journal of neuroendocrinology. 2008, Vol 20, pp 130-138, issn 0953-8194, 9 p., SUP1Conference Paper

Effets comportementaux des cannabinoïdes: Données animales = Behavioral effects of cannabinoids : animal dataTHIEBOT, M.-H; CHAPERON, F.Douleur et analgésie. 2001, Vol 14, Num 4, pp 193-206, issn 1011-288XArticle

In vitro and in vivo evaluation of ¹¹C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB₁ receptorsTSUJIKAWA, Tetsuya; ZOGHBI, Sami S; JINSOO HONG et al.NeuroImage (Orlando, Fla.). 2014, Vol 84, pp 733-741, issn 1053-8119, 9 p.Article

Le système endocannabinoïde : des effets métaboliques aux effets neuroendocriniens = Endocannabinoid system : from metabolic to neuroendocrine effectsBRICAIRE, L; BRUE, T.Annales d'endocrinologie. 2007, Vol 68, issn 0003-4266, S12-S17, SUP1Article

Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptorsBATKAI, Sandor; PACHER, Pal; JARAI, Zoltan et al.American journal of physiology. Heart and circulatory physiology. 2004, Vol 56, Num 2, pp 595-600, issn 0363-6135, 6 p.Article

Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB₁ and CB₂ receptorsGOVAERTS, Sophie J; MUCCIOLI, Giulio G; HERMANS, Emmanuel et al.European journal of pharmacology. 2004, Vol 495, Num 1, pp 43-53, issn 0014-2999, 11 p.Article

Similar in vitro pharmacology of human cannabinoid CB₁ receptor variants expressed in CHO cellsJING CHEN XIAO; JEWELL, James P; LIN, Linus S et al.Brain research. 2008, Vol 1238, pp 36-43, issn 0006-8993, 8 p.Article

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptorsSAVINAINEN, J. R; SAARIO, S. M; LAITINEN, J. T et al.Acta physiologica (Print). 2012, Vol 204, Num 2, pp 267-276, issn 1748-1708, 10 p.Conference Paper